Road Closures Near 801 Broadway Parking Garage
Effective June 18, 2014 - Turn onto Ashland Ave from Broadway, to access the Kennedy Krieger parking garage. Please allow more time for travel to appointments.
Detour Route and more information.
News & Updates
Find A Specialist
Resource Finder at Kennedy Krieger Institute
A free resource that provides access to information and support for individuals and families living with developmental disabilities.
Gerald V. Raymond, M.D.
Kennedy Krieger Institute
707 N. Broadway
Baltimore, MD 21205
Phone: (443) 923-9200
Gerald Raymond is a pediatric neurologist and research scientist at Kennedy Krieger Institute. Dr. Raymond is also a professor of neurology at Johns Hopkins University, and on the medical staff in the Departments of Pediatrics and Neurology at Johns Hopkins Hospital.
Dr. Raymond graduated in 1980 from Fairfield University with a bachelor's of science in biology and went on to graduate from University of Connecticut in 1984. Upon graduation, he became a resident in pediatrics at Johns Hopkins University and in neurology at Massachusetts General Hospital. He completed training in clinical genetics at Harvard in 1990.
For the past 10 years, Dr. Raymond has been a pediatric neurologist at Kennedy Krieger Institute. He joined Johns Hopkins School of Medicine in 1993, and is presently an associate professor in neurology. He serves on the medical staff in the Departments of Pediatrics and Neurology at Johns Hopkins Hospital.
Dr. Raymond is a pediatrician, a geneticist, and a neurologist with a special interest in developmental and neurogenetic disorders affecting children and adults.
Dr. Raymond’s work combines careful clinical analysis with technological advances in neuroimaging, genetics and neuroscience to permit delineation and characterization of neurogenetic disorders. His activities are at the interface between clinical neurology and basic sciences which provide a unique opportunity to understand the developing brain, the biological basis of disease and to develop new strategies for prevention and therapy. He has completed an FDA-funded study of the treatment of peroxisome assembly disorders using the compound docosahexaenoic acid with arachidonic acid and is presently principal investigator of a study examining adrenomyeloneuropathy, the adult form of the condition adrenoleukodystrophy.
- 1 of 3